WuXi Accused Of Shorting Investors In Go-Private Deal
A putative class of investors alleged in New York federal court on Thursday that pharmaceutical research and development company WuXi PharmaTech kept them in the dark about plans to spin off...To view the full article, register now.
Already a subscriber? Click here to view full article